Mallen Adrianne R, Townsend Mary K, Tworoger Shelley S
Department of Gynecologic Oncology, Moffitt Cancer Center/University of South Florida, 12902 Magnolia Drive MCC-GME, Tampa, FL 33612, USA.
Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive MCC-CANCONT, Tampa, FL 33612, USA.
Hematol Oncol Clin North Am. 2018 Dec;32(6):891-902. doi: 10.1016/j.hoc.2018.07.002. Epub 2018 Sep 27.
Ovarian cancer is the leading gynecologic killer of women in the United States. At diagnosis, most women present with advanced-stage disease. There are currently no effective screening strategies for average-risk women, thus understanding disease development and progression is important for developing risk-reduction strategies and identifying high-risk populations who can benefit from preventive surgery. Cancer epidemiology has greatly contributed to the understanding of this complex, heterogeneous disease by identifying various factors that may modify disease development. This article comprehensively reviews the current evidence regarding risk factors using the newest epidemiologic research for further insight into this lethal disease.
卵巢癌是美国女性妇科疾病的首要杀手。在确诊时,大多数女性已处于疾病晚期。目前尚无针对平均风险女性的有效筛查策略,因此了解疾病的发展和进展对于制定降低风险策略以及识别可从预防性手术中获益的高危人群至关重要。癌症流行病学通过识别可能影响疾病发展的各种因素,为理解这种复杂的异质性疾病做出了巨大贡献。本文利用最新的流行病学研究全面回顾了关于风险因素的现有证据,以进一步深入了解这种致命疾病。